Avenue Therapeutics Inc. buy Aegis
Start price
03.04.23
/
50%
€1.09
Target price
03.04.24
€29.35
Performance (%)
-87.88%
End price
04.04.24
€0.13
Summary
This prediction ended on 04.04.24 with a price of €0.13. Massive losses of -87.88% were the result for the BUY prediction by Aegis. Aegis has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Avenue Therapeutics Inc. | - | - | - |
iShares Core DAX® | -1.215% | 4.788% | 16.604% |
iShares Nasdaq 100 | -1.911% | 1.109% | 19.364% |
iShares Nikkei 225® | -3.171% | 5.626% | 10.519% |
iShares S&P 500 | -1.029% | 1.792% | 20.514% |
Comments by Aegis for this prediction
In the thread Avenue Therapeutics Inc. diskutieren
Avenue Therapeutics, Inc. (NASDAQ: ATXI) is now covered by analysts at Aegis. They set a "buy" rating and a $32.00 price target on the stock.
Ratings data for ATXI provided by MarketBeat
In the thread Trading Avenue Therapeutics Inc.
Die von Aegis gewählte maximale Laufzeit wurde überschritten